Background/Aims: Recent reports showed that proteasome subunit alpha type-7 (PSMA7) was overexpressed in colorectal cancer. To investigate the mechanism of PSMA7 in promotion of colorectal cancer, we screened for its interaction partners. Methods and Results: This study found that PSMA7 associated with nucleotide-binding oligomerization domain-containing protein 1 (NOD1) by yeast two-hybrid screening, co-immunoprecipitation (IP), and GSTpull down assay. As shown by Western blotting and ubiquitin assay, PSMA7 downregulated the expression of NOD1 in a proteasome-dependent manner. Overexpression of PSMA7 in HCT116 cells resulted in an inhibition of NOD1-mediated apoptosis and NF-kB activation, whereas knockdown of PSMA7 by RNA interference enhanced NOD1 activity. Conclusion: Our data suggest that PSMA7 is a negative regulator of the NOD1, and may promote tumor growth by its inhibitory role on NOD1.
PSMA7 Directly Interacts with NOD1 and Regulates its Function

Introduction
Colorectal cancer is the third most common malignant neoplasm and the second leading cause of cancer deaths worldwide. It is widely accepted that the activation of oncogene k-ras and the inactivation of tumor suppressor genes p53, DCC/SMAD4, and APC, contribute to the progression and metastasis of colorectal cancer [1] [2] [3] [4] . However, the molecular pathogenesis of colorectal cancer remains poorly understood. Recent studies suggested that PSMA7, an alpha-type subunit of the proteasome, is overexpressed in colorectal cancer and associated with its hepatic metastasis [5] [6] [7] . The proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator [8] . The 19S complex is required for the recognition of poly-ubiquitinated protein substrates that are degraded inside the 20S core complex. PSMA7 is a subunit of proteasome 20S core complex. The role of PSMA7 in proteasome is well defined; however its function in tumorigenesis has not been fully elucidated.
NOD1 is a cytoplasmic protein that belongs to Nod-like receptor (NLR) family [9] . The primary function of this gene is thought to be a sensor of specific bacterial molecules, g-D-
glutamyl-meso-diaminopilemic acids (iE-DAP), which are derived from the bacterial cell wall peptidoglycan. NOD1 binding to its ligands triggers the secretion of pro-inflammatory cytokines through the activation of both NF-kB and MAPK pathways. Nod1 deficient mice or cell lines are shown to be more susceptible to certain pathogenic microbes, such as Shigella flexneri, Helicobacter pylori, and Listeria monocytogenes [10] [11] [12] . Recent reports have shown that Nod1 controlled tumor cell growth beyond its role in responses to infection. Nod1 has been shown to increase apoptosis, and overexpression of Nod1 resulted in an activation of caspase-8-promoted cell death [13] . In breast cancer, the absence of Nod1 was associated with tumor growth and an increased sensitivity to estrogen stimulation [14] . It was also reported that Nod1 protected the intestine from inflammation-induced tumorigenesis [15] .
In this study, we demonstrate that PSMA7 physically interacts with NOD1 and decreases the expression of NOD1, providing a novel mechanism for PSMA7 promotes tumorigenesis.
Materials and Methods
Cell culture and tansfection
Human embryonic kidney cell line 293 and colon carcinoma cell line HCT116 were grown in DMEM supplemented with fetal bovine serum (FBS, Hyclone) and maintained at 37 °C under 5% CO 2 in a humidified incubator. For transfections, cells were plated to 85-90% confluency and transfected with Lipofectamine 2000 (Invitrogen). For transient knockdown of PSMA7, PSMA7 siRNA oligonucleotide (Santa Cruz Biotechnology) was transfected following the manufacturer's instructions.
Luciferase reporter assays
The 293 cells were plated in 24-well plates and transfected with NF-kB luciferase reporter (pNF-kBluc, 100 ng) and pRL-TK (2 ng) together with 100 ng plasmid encoding NOD1 and increasing amounts of Myc-PSMA7 plasmid. After 24 h, transfected cells were collected, and luciferase activity was measured using the dual luciferase reporter assay kit (Promega Corp.). All experiments were repeated at least three times.
IP and immunoblot analysis
Cell extracts were prepared in NP-40 lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 1% NP-40 in the presence of Complete ® protease inhibitor cocktail (Roche Applied Science). Supernatants of cell lysates were subjected to IP with anti-Flag (Sigma-Aldrich). For endogenous IP, anti-NOD1 antibody and protein A/G Sepharose beads were added into the lysates instead. The immunoprecipitated proteins were blotted onto PVDF membrane after separated on 8-12% SDS-PAGE, and detected with anti-Flag, antiMyc (Sigma-Aldrich), anti-PSMA7 (Proteintech), anti-caspase 8, anti-NOD1 (Santa Cruz Biotechnology), or anti-b-tubulin (Sigma-Aldrich) antibody.
GST-pull down and far-Western
For GST-pull down experiments, cell lysates containing Flag-NOD1 were incubated for 2 h at 4 °C with 1 µg purified GST or GST-PSMA7 fusion proteins bound to glutathione beads. The immunoprecipitates were washed with NP-40 lysis buffer and then subjected to immunoblotting analysis. For far-Western assay, Flag-NOD1 purified from 293 cells was separated by SDS-PAGE and then blotted onto nitrocellulose (NC) membranes, which were subsequently incubated with purified GST or GST-fusion proteins for 1 h at room temperature. The GST fusion proteins binding to NC were probed with anti-GST antibody.
In vivo ubiquitination assays
Cells were co-transfected with Flag-NOD1, HA-ubiquitin, and different doses of Myc-PSMA7. After 24 h, cells were grown in medium containing MG132 (20 µM) for 8 h. Immunoprecipitates with anti-Flag agarose were analyzed by immunoblotting with anti-HA antibody. Flag-NOD1 was used as equal loading control.
Analysis of apoptosis by flow cytometry
Annexin V Staining Kit was purchased from BD Pharmingen (San Jose, CA, USA). After transfection with expression plasmid or siRNA for 48 h, the cells were digested with trypsin to make a single-cell suspension, washed 3 times with PBS, resuspended in binding buffer, and adjusted to a density of 1 × 10 6 cells/ml. In each tube, 100 µl of cell suspension were added with 15 µl of FITC-conjugated Annexin V, incubated at 4 °C for 20 min, and analyzed then for cell apoptosis by flow cytometry.
Results
PSMA7 interacts with NOD1 in vivo and in vitro
To study the mechanism of tumorigenesis induced by PSMA7 in colorectal cancer, interaction partners of PSMA7 were screened by yeast two-hybrid assay. PSMA7 was cloned into pGBKT7 vector and used as bait. From 7 × 10 6 transfectants, NOD1 was identified (data not shown). To demonstrate the results of yeast two-hybrid screening, 293 cells were cotransfected with Flag-tagged NOD1 and Myc-tagged PSMA7. Following transfection, co-IP experiment was performed by anti-Flag agrose. As expected, PSMA7 was detected in the IP complex with NOD1, but not with a negative control (Fig. 1a) . Then, the specificity of the interaction between endogenous NOD1 and PSMA7 was also examined by co-IP analysis using NOD1 specific antibody and control normal IgG, which demonstrated that NOD1 was associated with endogenous PSMA7 in HCT116 cells (Fig. 1b) . To show the interaction of PSMA7 and MAVS in vitro, cell lysates from 293 cells expressing Flag-NOD1 were incubated with GST or GST-PSMA7 fusion protein. As shown in Fig. 1c , MAVS was associated with GST-PSMA7, but not GST. To determine the direct binding between these two proteins, immunoprecipitates prepared from cells expressing Flag-NOD1 were subjected to SDS-PAGE and then blotted onto NC membrane. After incubation with purified soluble GST-PSMA7, the NC membrane was immunoblotted with an HRP-conjugated anti-GST antibody. The results showed that NOD1 bound to PSMA7 directly (Fig. 1d) .
PSMA7 downregulates the expression NOD1
Nod1 plays a crucial role in preventing tumorigenesis by protecting the intestinal epithelial barrier against injury and bacterial translocation. We detected the effect of PSMA7 on the expression of NOD1. Increasing PSMA7 expression plasmids were co-transfected with the same amounts of NOD1 into HCT116 cells, a significant reduction of NOD1 was found with PSMA7 transfection in a dose dependent manner (Fig. 2a) . Semi-quantitative PCR showed that NOD1 mRNA level was not affected by PSMA7 overexpression (Fig. 2b) . Endogenous NOD1 was also downregulated by PSMA7 plasmid transfection (Fig. 2c) . To confirm that the degradation is mediated by proteasome, HCT116 cells were transfected with PSMA7 and treated with proteasome inhibitor MG132 or DMSO (control). Fig. 2d shows that MG132 was able to reverse the reduction of NOD1, indicating that proteasome pathway is involved in PSMA7 mediated NOD1 instability.
PSMA7 blocks NOD1-mediated apoptosis and NF-kB activation
Activation of Nod1 initiates a variety of cellular responses including NF-kB activation and apoptosis. To assess the functional effect of PSMA7 on the reduction of NOD1, apoptosis induced by NOD1 was detected. With the addition of PSMA7, apoptosis caused by the activation of NOD1 was decreased (Fig. 3a) . The cleavage of pro-caspase 8 produces the active form of caspase-8, which is a critical step in apoptosis event, and several lines of evidence showed that NOD1-dependent apoptosis is a caspase 8-mediated event [10] . Caspase 8 was cleaved in the NOD1 overexpressing cells; however, this cleavage was partially decreased by b: HCT116 cells were transfected with siPSMA7 or control siRNA together with NF-kB luciferase and pRL plasmid. After treated with gTriDAP, the luciferase activity was measured and normalized to transfection efficiency. c: HCT116 cells were treated with siPSMA7 or control siRNA for 48 h, and then the cells were treated by gTriDAP for 24 h. Apoptosis was analyzed by FITC-Annexin V staining and were transfected with increasing amounts of PSMA7 plasmid, NF-kB luciferase and pRL plasmids, and then stimulated with gTriDAP for 24 h. NF-kB activation in response to NOD1 ligands in the absence or presence of PSMA7 was measured by luciferase activity assay. e: HCT116 cells were transfected with PSMA7 and then stimulated with gTriDAP for 24 h, the amount of IL-8 from the supernatants was mesueaed by ELISA.
flow cytometry assay. d: The 293 cells were transfected with increasing amounts of PSMA7, Flag-NOD1, and HA-ubiquitin or HA-ubiquitin (k48, k63) plasmids. After 24 h, cells were added with MG132 for an additional 6 h. Anti-Flag immunoprecipitates were analyzed by immunoblotting with HA and Flag antibody. PSMA7 (Fig. 3b) . The effect of PSMA7 on NF-kB activity induced by NOD1 was also analyzed. The 293 cells were transfected with NF-kB luciferase reporter plus equal amount of NOD1 and increasing amounts of PSMA7 plasmids. As shown in Fig. 3c , NOD1 overexpression in 293 cells activated the NF-kB promoter, whereas such activation was inhibited by PSMA7 in a dose-dependent manner. Addition of gTriDAP to HCT116 cells induced increasing NF-kB promoter activity, and this activation was inhibited by PSMA7 too (Fig. 3d) . We detected the role of PSMA7 on NF-kB associated gene (IL-8) stimulated by gTriDAP. From Fig. 3e , we can see that PSMA7 also downregulated IL-8 expression by ELISA.
Depletion of PSMA7 increases NOD1 expression and activity
As shown in Fig. 2, NOD1 was downregulated by PSMA7 plasmid transfection; consistently, specific knockdown of PSMA7 expression by RNA interference increased endogenous NOD1 abundance as compared to control siRNA in HCT116 cells (Fig. 4a) . gTriDAP is a natural PAMP (pathogen-associated molecular pattern) of NOD1. In this experiment, we used the gTriDAP to activate the endogenous NOD1 signal pathway in HCT116 cells. Transfection of PSMA7-specific siRNA, but not control siRNA enhanced NF-kB luciferase activity induced by NOD1 activation, in coincidence with the inhibitory effects of PSMA7 in overexpression experiments (Fig. 4b) . The siPSMA7 also increased the apoptosis induced by gTriDAP treatment (Fig. 4c) .
PSMA7 increases ubiquitination of NOD1
To further explore the mechanism by which PSMA7 mediated NOD1 degradation, 293 cells were transfected with plasmids expressing Flag-NOD1, Myc-PSMA7, and HA-ubiquitin. Twenty hours after transfection, MG132 was added to a final concentration of 20 nM for 12 h. As shown in Fig. 4d , PSMA7 led to an increased ubiquitination of NOD1. We used Lys48 (K48) and Lys63 (K63) only ubiquitin expression plasmid to find out the form of ubiquitination linked. From Fig. 4d , we confirmed that PSMA7 promoted K48-linked poly-ubiquitination status of NOD1, but not K63-linked form.
Discussion
Tumorigenesis is a complex process in which normal cells experience multiple genetic and epigenetic alterations to transform into malignant tumor cells. Recent findings indicated the relationship between PSMA7 expression and the clinicopathological features of colorectal cancer and suggested that PSMA7 may be molecular targets for colorectal cancer therapy [5, 6, 16] . However, it is unknown how PSMA7 critically regulates the tumorigensis of colorectal cancer cells. In this report, several lines of evidence supported the notion that PSMA7 functions partially through downregulation NOD1: 1) PSMA7 interacts with NOD1 as determined by GST pull down, co-IP, and far-Western; 2) PSMA7 increases NOD1 degradation by promoting its ubiquitination; 3) PSMA7 downregulates NOD1 expression and NOD1-mediated apoptosis and NF-kB activity; and 4) knockdown of PSMA7 partially rescued the expression and activity of NOD1.
As a component of proteasome, PSMA7 interacts with certain proteins and targets them for proteasome-dependent degradation. Cho et al. showed that PSMA7 bind with hypoxiainducible factor-1a and promote its degradation through proteasome-dependent pathway [17] . HBVx (hepatitis B virus X protein) is a binding partner with PSMA7, which is degraded by the ubiquitin-proteasome system [18, 19] . Jia et al. showed that PSMA7 impairs IFN-b promoter activity by increasing ubiquitination of mitochondrial antiviral signaling (MAVS) during viral infection [20] . Because proteasome subunits can be exchanged with exogenous subunits in vivo and in vitro, PSMA7 may have a role in recruiting specific substrates to the proteasome complex through subunit exchanging and proteasome assembling [21] . The present study finds that NOD1 is a novel substrate of PSMA7 and also trapped by the latter in proteasome-dependent degradation, which can be blocked by the addition [22] . As an important pattern recognition sensor, NOD1 monitors damage by recognition of the derivatives of lipopolysaccharides, and thus protects host from colitis and inflammation-induced tumorigenesis. Recent study shows that NOD1 also promotes apoptosis [13, 14, 23] , and defective apoptosis represents a major causative factor in the development and progression of cancer [24] . To better understand functional effects and mechanisms involving in the regulation of NOD1, a number of proteins that interact with NOD1 have been identified and characterized. Previous reports showed that while RIPK2, SGT1, and BID are positive regulators, CENTB1 is the only one that directly and negatively regulates NOD1 activity [25, 26] . CENTB1 downregulates NF-kB activation via NOD1 and NOD2 pathways; however, the role of CENTB1 in regulation of apoptosis induced by NOD1 was not detected. Here, we report a novel negative regulator of NOD1, PSMA7, which downregulates both the expression and activity of NOD1 and inhibits the apoptosis induced by NOD1. In summary, we have identified a novel regulatory function of PSMA7 in colorectal cancer. By forming a complex with NOD1, PSMA7 promotes NOD1 degradative polyubiquitination, decreases its protein expression and apoptosis induced by NOD1 activation. Our results also suggest a possible mechanism of PSMA7 in promoting colorectal cancer by impairing the function NOD1 and intestinal homeostasis. Therefore, PSMA7 may form a potential target for the development of clinical therapy for tumors caused by NOD1 dysfunction. 
